Stockreport

Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer [Yahoo! Finance]

Kronos Bio, Inc.  (KRON) 
PDF dedicated to developing small molecule therapeutics that address cancers and other diseases driven by deregulated transcription, today announced that it has appointed De [Read more]